| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9744 | DTPA-TOC trifluoroacetate |
9744.0001: 1 mg per vial 9744.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for radiolabelled DTPA-TOC
Ligand for somatostatin receptors |
||
| Molar Mass: 1410.57 | ||
| C63H87N13O20S2 | ||
| [147790-81-6] (net peptide) | ||
| Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: CA index name: L-Cysteinamide, N-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (3→8)-disulfide |
||
|
Synonymes: 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.; L-Cysteinamide, N-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (3→8)-disulfide, [R-(R*,R*)]- |
||
|
Literature: 1. De Jong M. et al. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer 1998, 75, 406-411. |
||
| date of product catalogue issue: 21 Decmber 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1